Determining key features of effective depression interventions

The effect size analyses treated short (six weeks to four months), medium (five to eight months), and long (nine to twelve months) outcomes separately. We also measured intervention impact (high, medium, low and little or none) for each study based on reviewer ratings of de-identified sets of study...

Full description

Main Author: Rubenstein, Lisa V.
Corporate Authors: United States Department of Veterans Affairs, United States Veterans Health Administration, Greater Los Angeles Veterans Affairs Healthcare System (U.S.), Southern California Evidence-Based Practice Center/RAND.
Other Authors: Williams, John W., Danz, Marjorie, Shekelle, Paul G.
Format: eBook
Language:English
Published: [Washington, D.C.] Department of Veterans Affairs, Health Services Research & Development Service [2009], 2009
Series:Evidence-based synthesis program
Subjects:
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
LEADER 06164nam a2200565 u 4500
001 EB000942653
003 EBX01000000000000000736243
005 00000000000000.0
007 tu|||||||||||||||||||||
008 150223 r ||| eng
100 1 |a Rubenstein, Lisa V. 
245 0 0 |a Determining key features of effective depression interventions  |h Elektronische Ressource  |c investigators, Lisa V. Rubenstein ... [et al.] ; statistician, Marika Suttorp ; research assistant, Breanne Johnsen 
260 |a [Washington, D.C.]  |b Department of Veterans Affairs, Health Services Research & Development Service  |c [2009], 2009 
505 0 |a Includes bibliographical references 
653 |a United States / s 
653 |a Patient Satisfaction / s 
653 |a Outcome Assessment (Health Care) 
653 |a Anxiety Disorders / complications / s 
653 |a Humans / check tag / s 
653 |a Patient Care Team 
653 |a Randomized Controlled Trials as Topic 
653 |a Depressive Disorder / therapy 
653 |a Stress Disorders, Post-Traumatic / complications / s 
653 |a Substance-Related Disorders / complications / s 
653 |a Dementia / complications / s 
653 |a Patient Care Management / methods / s 
653 |a Dysthymic Disorder / complications / s 
653 |a Outcome Assessment (Health Care) / s 
653 |a Depression / prevention & control / s 
700 1 |a Williams, John W. 
700 1 |a Danz, Marjorie 
700 1 |a Shekelle, Paul G. 
710 2 |a United States  |b Department of Veterans Affairs 
710 2 |a United States  |b Veterans Health Administration 
710 2 |a Greater Los Angeles Veterans Affairs Healthcare System (U.S.) 
710 2 |a Southern California Evidence-Based Practice Center/RAND. 
041 0 7 |a eng  |2 ISO 639-2 
989 |b NCBI  |a National Center for Biotechnology Information 
490 0 |a Evidence-based synthesis program 
500 |a Title from PDF cover. - "March 2009.". - "Prepared for: Department of Veterans Affairs, Veterans Health Administration, Health Services Research & Development Service, Washington, DC 20420. Prepared by: Greater Los Angeles Veterans Affairs Healthcare System/Southern California/RAND Evidence-based Practice Center, Los Angeles, CA.". - Mode of access: World Wide Web 
856 |u http://www.ncbi.nlm.nih.gov/books/NBK48533  |3 Volltext 
856 |u http://www.hsrd.research.va.gov/publications/esp/BPH-2007.pdf  |3 Volltext 
082 0 |a 140 
082 0 |a 610 
520 |a The effect size analyses treated short (six weeks to four months), medium (five to eight months), and long (nine to twelve months) outcomes separately. We also measured intervention impact (high, medium, low and little or none) for each study based on reviewer ratings of de-identified sets of study outcomes, including adherence, patient satisfaction, and functioning. We eliminated variables with inadequate distributions for meaningful quantitative analysis, using a rule of thumb of at least three studies per variable category. We carried out univariate and multivariate regression to determine relationships between intervention and evaluation features and effectiveness. Finally, we conducted cross-case qualitative analysis (Miles and Huberman 1994) of intervention and evaluation features, including comorbidities, against intervention impact 
520 |a Our main research question was whether there are specific design features of collaborative care interventions that are consistently associated with greater impact on depression symptoms compared to a usual care control group. We also aimed to explore additional outcomes including patient satisfaction and functioning. In addition, we asked whether there were specific design features of randomized trial evaluations of collaborative care that were associated with consistently greater effects. Secondarily, we aimed to assess whether any patient characteristics, such as comorbidities, were associated with differential collaborative care effects, and the degree to which model effects persisted over time. We investigated these goals based on the following research questions.  
520 |a Studies were high quality randomized trials of depression collaborative care interventions compared to usual care that incorporated at least two features of the chronic illness care model. At least one of these features had to directly support patients in completing depression treatment. We did not review studies that only sought to change primary care clinician behavior (e.g., using reminders), without an additional patient-directed component, such as care management. We contacted authors extensively to identify, clarify, or verify study variables such as chronic illness care features or patient population characteristics. We began our analyses by assessing correlations between features. For study outcomes, we evaluated the effect size across studies for changes in depression symptoms, and relative risk across studies for changes in rates of resolution of depression. For these analyses we used study effect sizes comparing intervention to usual care arms as the unit of analysis.  
520 |a (1) Primary Research Question: What is the core set of intervention features that characterize collaborative care interventions, and which additional features are most linked to enhanced outcome effects? (2) Secondary Research Question: Are there specific evaluation features among randomized trials of collaborative care that are associated with effect size differences, independently of intervention features? (3) Secondary Research Question: To what extent is collaborative care more effective than usual care for decreasing depressive symptoms among patients with comorbid mental health conditions (PTSD, dementia, anxiety, dysthymia, substance abuse) or medical conditions? Methods: We used a set of articles identified and preliminarily reviewed as part of an earlier, nonquantitative literature review on depression care models (Williams, Gerrity et al. 2007) to carry out quantitative meta-regression analysis of collaborative care features.